Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Taiwan Semiconductor Manufacturing Company reports Q3 results on October 15 with the stock having given back some ground ahead of the print, but analyst conviction pointing firmly higher.
The ADR slipped 1% on Friday and is down 4.1% on the week to $453.31, a pullback from what was a strong September. Yet options traders are not reading that weakness as cause for alarm. The put/call ratio at 1.04 is almost exactly in line with its 20-day average of 1.045, with a z-score of just -0.09. There is no notable defensive hedging into this event. Short sellers are equally relaxed: short interest has fallen roughly 8.6% over the past month to around 27.4 million shares, and the lending market is effectively without constraint. Availability is near unlimited, with over 172 million shares available to borrow against negligible short demand. Cost to borrow has picked up roughly 40% on the week to 0.43%, but as noted in last week's ORTEX note, the absolute level is still firmly low. Nothing in the lending or options market points to unusual anxiety about the print.
Analyst sentiment is the clearest bullish signal in the setup. Barclays raised its price target to $665 from $650 this week while maintaining Overweight, the second target increase from the firm since July. Before that, Bernstein lifted its target to $554 from $430 in August, and BofA Securities moved its target to $590 from $490 in June. The mean target across the consensus stands at $555, roughly 22% above the current price. Bulls point to TSMC's market-share dominance in advanced nodes, its 60 to 65% foundry revenue share, and two consecutive quarters of strong results: Q1 revenue of $35.9 billion and Q2 of $40.2 billion, with gross margins running at 66 to 67.7%. The bear argument is not about execution but about vulnerability. Cyclicality, foreign exchange mismatch between USD revenues and NTD costs, and the risk that process technology progression slows are the main concerns. TD Cowen, notably, holds a Hold rating with a $440 target, below the current price, suggesting at least one credible voice thinks valuation is full even after this week's pullback.
The ownership picture adds some context. Capital Research added 8.5 million shares in the quarter to September, BlackRock added 19.5 million, and Vanguard added 9.3 million. These are incremental rather than conviction-changing additions, but the direction of flow at the largest institutional holders is positive. The prior Q3 print, July 16, produced a sharp one-day move of -5% before the stock nearly recovered all of that within five days. That reaction profile, a violent initial move followed by stabilisation, is worth carrying into the read this week.
The October 15 print is less a test of whether TSMC is growing and more a test of whether Q3 margins and the capital expenditure outlook, with the company investing $60 to $64 billion annually, can sustain the premium the consensus is now pricing in.
See the live data behind this article on ORTEX.
Open TSM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
